spacer
home > ict > winter 2017 > survey time
PUBLICATIONS
International Clinical Trials

Survey Time

For drug developers, the transition from traditional, 100% source document verification (SDV) to risk-based monitoring (RBM) strategies requires a sweeping transformation in clinical trial operations. RBM impacts everything Ė from trial design and data management platforms to the roles and skillsets of clinical project teams. Effective change management can identify barriers to implementing RBM, inform the development of training programmes and guide interventions to overcome obstacles among operations teams.

It has been found that incorporating surveys of clinical trial managers (CTMs) and clinical research associates (CRAs) is an effective way to gauge adoption progress and to refine change management processes.

New Mindset

PPD has conducted more than 150 RBM trials since late 2013. Early experience has shown that implementing risk-based approaches necessitates new ways of thinking and executing trials.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
As Executive Director of AIM at PPD, Nicole Stansbury leads the development and implementation of the organisationís RBM strategy. She holds a Bachelorís degree in Animal Science from Texas A&M University, US.
spacer
Nicole Stansbury
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta and Leeds University awarded £3.8m Medical Research Council funding to develop new diagnostic tests


More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 
Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement